|
Advertisement | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
J. Biol. Chem., Vol. 282, Issue 32, 23591-23602, August 10, 2007
Cytosolic Aspartate Aminotransferase, a New Partner in Adipocyte Glyceroneogenesis and an Atypical Target of Thiazolidinedione* 1![]() 2![]() ![]() ![]() ¶3 ¶![]() 4
From the
We show that cytosolic aspartate aminotransferase (cAspAT) is involved in adipocyte glyceroneogenesis, a regulated pathway that controls fatty acid homeostasis by promoting glycerol 3-phosphate formation for fatty acid re-esterification during fasting. cAspAT activity, as well as the incorporation of [14C]aspartate into the neutral lipid fraction of 3T3-F442A adipocytes was stimulated by the thiazolidinedione (TZD) rosiglitazone. Conversely, the ratio of fatty acid to glycerol released into the medium decreased. Regulation of cAspAT gene expression was specific to differentiated adipocytes and did not require any peroxisome proliferator-activated receptor
Received for publication, December 4, 2006 , and in revised form, May 22, 2007. * This work was supported in part by INSERM, CNRS, the Université René Descartes, the Association Claude Bernard, and the Association pour la Recherche contre le Cancer. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact. 1 Recipient of a fellowship from the Ministère de l'Education Nationale et de la Recherche and of the 2003 prize from the French Nutrition Society. Present address: INSERM U755, Paris F-75004, France. 2 Recipient of a fellowship from the Agence Nationale pour la Recherche sur le Sida. 3 Supported by Association pour la Recherche contre le Cancer Grant 3511 (to J.-L. Danan). 4 To whom correspondence should be addressed: INSERM U680, Université Pierre et Marie Curie, Facultéde Médecine, 27, rue de Chaligny, 75012 Paris, France. Tel.: 33-1-4001-1351; Fax: 33-1-4001-1352; E-mail: antoine{at}st-antoine.inserm.fr.
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Advertisement | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||